19 Oct 2017
Orally administered semaglutide successfully reduces blood glucose in type 2 diabetes patients, and also promotes weight loss, according to research published in JAMA.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024